EGFR and gastric cancer: For example, we have previously shown that using linear mixed models, EGFR gene expression was identified as the best single-gene biomarker for predicting the efficacy of Erbitux, an EGFR mAb, on patient-derived xenograft (PDX) models of gastric cancer.